Aventix

1. 30 Sep 2026

   Seed

   €1.2M

   Cumulative €1.2M

Amounts in EUR, converted at the ECB rate on the event date. Funding totals exclude debt, grants and state aid; rounds whose instrument is not yet established are still counted. Every figure links to its source.

• Funding30 Sep 2026EUR 1.2M

  Aventix has raised 1.2 million euros in a funding round led by Kost Capital to support the commercial rollout of its first product, Scarlett 01.

  ▸Source: Breakit

  “De står bland annat bakom Cellink, numera Bico. Nu tar serieentreprenörerna Erik Gatenholm och Hector Martinez in nya miljoner till sitt bioanalysbolag Aventix. Bolaget backas bland annat av Bodil…”

  Read at Breakit

• Erik Gatenholm

  Co-founder

• Hector Martinez

  Co-founder

What does Aventix do?

Aventix is a bioanalysis company based in Mölndal that builds tools for better laboratory analyses using AI. Its first product, Scarlett 01, is intended for use in chemistry, agriculture, pharmaceuticals, and cosmetics. By combining sensors with advanced software, Aventix aims to provide faster and more precise experimental results.

Where is Aventix headquartered?

Aventix is based in Sweden.

How much funding has Aventix raised?

Aventix has raised €1.2M (across 1 round · last 30 Sep 2026).

What was Aventix's latest funding round?

Aventix's most recent disclosed round was a seed round of €1.2M, announced 30 September 2026.

Who has invested in Aventix?

Investors in Aventix include Kost Capital, Voima Ventures.